Med.E.A Srl educational programs are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products.
These views are the responsibility of the named speakers and do not represent an endorsement or recommendation on the part of Med.E.A. Srl. Our educational activities are supported by independent grants from the Healthcare business of Merck KGaA, Darmstadt, Germany; FUJIFILM EUROPE GMBH, Fujifilm Italia S.p.A., FUJIFILM France S.A.S., Androfert Andrology & Human Reproduction Clinic; MVZ Fertility Center Hamburg GmbH; University of North Carolina at Chapel Hill; Reproductive Medicine Agency (Nova Clinic)
Overview
The role of luteinizing hormone (LH) during folliculogenesis has intrigued the scientific and medical community for at least three decades. There is now an emerging galaxy of research that is exploring this enigmatic subject. The availability of recombinant drugs is offering, for the first time, the opportunity to examine the role of follicle stimulating hormone and LH separately. An emerging topic during last year’s conference was the role of LH supplementation in improving outcomes in a subgroup of low prognosis patients selected according to the POSEIDON classification.
During this online journey, the management of these low prognosis patients’ was discussed in detail. Notably, we moved beyond controlled ovarian stimulation to further investigate the involvement of LH in personalizing the luteal phase and in male infertility. In addition, the extra-gonadal effects of LH, including potential immunomodulation at the endometrium, is part of the agenda.
Following the precedent set at last year’s conference, considerable time was devoted to basic science, alongside such controversial issues as progesterone rise and pharmacogenomics. This year we had attracted prominent scientists from the worlds of endocrinology, andrology, immunology, and embryology to take part in our engaging exploration of the LH galaxy.
Learning Objectives
The online journey left with the ability of users:
- Understand the importance of luteinizing activity during folliculogenesis and beyond.
- Understand the dynamics of hypothalamic-pituitary axis in the pathogenesis of hypo- and normo-gonadotropic amenorrhea.
- Comprehend the concept of relative gonadotropin deficiency.
- Discuss and debate the management of low prognosis patients.
- Comprehend the clinical utility of the POSEIDON classification for the management of low prognosis women.
- Discover the clinical relevance of LH supplementation in ART.
- Appreciate the clinical relevance and pathogenesis of the progesterone rise during COS.
- Analyse the relevance of LH during the luteal phase and Introduce.
- Explore the potential role of LH in male infertility treatment.
Target Audience
This programme was designed for clinicians and biologists working in assisted reproductive medicine, who wanted to acquire up-to date information to improve their current practice.
Virtual World Conference on Luteinizing Hormone in ART · Second Edition
7 September · 31 December 2020
Accreditation
Language
Chairs
Faculty
Federico II University
Naples, Italy
Androfert – Andrology and Human Reproduction Clinic
Campinas, Brazil
Fertility Centre Hamburg
Hamburg, Germany
Paris, France
Aarhus University, Denmark
Louvain, Belgium
Heraklion, Greece
Nottingham, UK
Modena, Italy
Québec, Canada
London, UK
Rome, Italy
Preliminary Programme
Agenda
Scientific program
Moving away from earth: lessons from gonadotropins system
L1 Gonadotropins during ovarian cycles: the galaxy we know
Marc-André Sirard, Canada
L2 Hypothalamic amenorrhea and PCOS: two sides of the moon
Antonis Makrigiannakis, Greece
L3 The role of LH in male infertility: an altered connection between space and earth
Sandro Esteves
L4 Isoforms and polymorphisms of gonadotropins and their receptors in human reproduction: a partial eclipse
Daniele Santi, Italy
Flying through the stars: how to maximize success in controlled ovarian stimulation
L5 The periodic comet of POR: the novel POSEIDON classification
Sandro C. Esteves, Brazil
L6 Orbiting around clinical practice: management of the four POSEIDON groups
Carlo Alviggi, Italy
L7 Progesterone rise: the black hole of controlled ovarian stimulation
Jean-Noël Hugues, France
L8 Ongoing pregnancy rate as a valid endpoint: mapping a new star system
Sesh Sunkara, UK
A new universe to explore: medical trends in ART
L9 Antral follicle count: an “objective” dimension?
Nick Raine-Fenning, UK
L10 Follicular waves during the natural cycle: use of Duo-Stim in POSEIDON groups
Filippo M. Ubaldi, Italy
L11 Ovulation triggering: the big bang of an adequate luteal phase
Peter Humaidan, Denmark
L12 Landing in Real World “Data”
Philippe Lehert, Belgium
Video Lectures
Meet the Expert
> Meet the Expert 1
Moving away from earth: lessons from gonadotropins system
Marc-André Sirard / Canada
Antonis Makrigiannakis / Greece
> Meet the Expert 2
Moving away from earth: lessons from gonadotropins system
Sandro C. Esteves / Brazil
Daniele Santi / Italy
> Meet the Expert 3
Fly through the starts: how to maximize success in controlled ovarian stimulation
Sandro C. Esteves / Brazil
Carlo Alviggi / Italy
> Meet the Expert 4
Fly through the starts: how to maximize success in controlled ovarian stimulation
Jean-Noël Hugues / France
Sesh K. Sunkara / UK
> Meet the Expert 5
A new universe to explore: medical trends in ART
Nick Raine-Fenning / UK
Filippo M. Ubaldi / Italy
> Meet the Expert 6
A new universe to explore: medical trends in ART